These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29427835)

  • 1. Phenytoin-related ataxia in patients with epilepsy: clinical and radiological characteristics.
    Shanmugarajah PD; Hoggard N; Aeschlimann DP; Aeschlimann PC; Dennis GJ; Howell SJ; Reuber M; Grünewald RA; Hadjivassiliou M
    Seizure; 2018 Mar; 56():26-30. PubMed ID: 29427835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol-related cerebellar degeneration: not all down to toxicity?
    Shanmugarajah PD; Hoggard N; Currie S; Aeschlimann DP; Aeschlimann PC; Gleeson DC; Karajeh M; Woodroofe N; Grünewald RA; Hadjivassiliou M
    Cerebellum Ataxias; 2016; 3():17. PubMed ID: 27729985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar volume and long-term use of phenytoin.
    De Marcos FA; Ghizoni E; Kobayashi E; Li LM; Cendes F
    Seizure; 2003 Jul; 12(5):312-5. PubMed ID: 12810345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia in institutionalized patients with epilepsy.
    Young GB; Oppenheimer SR; Gordon BA; Wells GA; Assis LP; Kreeft JH; Lohuis NA; Blume WT
    Can J Neurol Sci; 1994 Aug; 21(3):252-8. PubMed ID: 8000981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dose-dependent relationship of chronic use of phenytoin and cerebellar atrophy in patients with epilepsy].
    Del Negro A; Dantas CD; Zanardi V; Montenegro MA; Cendes F
    Arq Neuropsiquiatr; 2000 Jun; 58(2A):276-81. PubMed ID: 10849627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Residual cerebellar ataxia following acute phenytoin intoxication].
    Awada A; Amene P; al Jumah M; al Beladi K
    Rev Neurol (Paris); 1999 Apr; 155(4):306-8. PubMed ID: 10367328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporal cerebellar atrophy following phenytoin therapy].
    Guerrero AL; Paniagua JA; Díaz Cascajo P; Cacho J; Arias P; Martín JA
    Neurologia; 1997; 12(6):259-61. PubMed ID: 9303595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin overdosage and cerebellar atrophy in epileptic patients: clinical and MRI findings.
    Luef G; Chemelli A; Birbamer G; Aichner F; Bauer G
    Eur Neurol; 1994; 34 Suppl 1():79-81. PubMed ID: 8001616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin and damage to the cerebellum - a systematic review of published cases.
    Ferner R; Day R; Bradberry SM
    Expert Opin Drug Saf; 2022 Jul; 21(7):957-977. PubMed ID: 35325581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsants, folic acid and memory dysfunction in epileptics.
    Butlin AT; Danta G; Cook ML
    Clin Exp Neurol; 1984; 20():57-62. PubMed ID: 6439448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CYP2C9 polymorphisms in phenytoin-related cerebellar atrophy.
    Twardowschy CA; Werneck LC; Scola RH; Borgio JG; De Paola L; Silvado C
    Seizure; 2013 Apr; 22(3):194-7. PubMed ID: 23298603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebellar atrophy and phenytoin poisoning. An MR study].
    Luef G; Marosi M; Felber S; Birbamer G; Aichner F; Bauer G
    Nervenarzt; 1993 Aug; 64(8):548-51. PubMed ID: 8413755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar Ataxia in Epilepsy Patient with Normal Serum Phenytoin Levels? Suspect Hyperammonemia.
    Juneja A; Anand KS
    Neurol India; 2021; 69(6):1869. PubMed ID: 34979716
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical seizures in phenytoin toxicity.
    Chua HC; Venketasubramanian N; Tan CB; Tjia H
    Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Phenytoin: Shepherd or Wolf in Disguise? Phenytoin-Induced Neurotoxicity: A Case Series.
    Arora M; Boruah DK; Thakker V; Bhanwra S
    Neurol India; 2021; 69(4):1014-1017. PubMed ID: 34507432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.
    Sener U; Zorlu Y; Karaguzel O; Ozdamar O; Coker I; Topbas M
    Seizure; 2006 Mar; 15(2):79-85. PubMed ID: 16414291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.